– Tetra Pharm Technologies y Glysious anuncian una colaboración para desarrollar fármacos combinados transdérmicos dirigidos al sistema endocannabinoide La colaboración aúna la experiencia de Tetra Pharm Technologies en tecnología de capacitación con el sistema patentado de administración…
Tetra Pharm Technologies y Glysious colaboran para desarrollar fármacos combinados transdérmicos
You Might Also Like
Sign Up For Daily Newsletter
Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Leave a comment
Leave a comment
Stay Connected
- Advertisement -
